PHAT Phathom Pharmaceuticals, Inc. - Common Stock
$9,67
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Tem 30, 2026
52 Haftlık Aralık
$8–$18
14% of range
Analist Derecelendirmesi
BUY
17 analysts
Fiyat Hedefi
$22
+122% upside
P/E (TTM)
-3.5
ROE
52.4%
Net Kâr Marjı
-126.4%
PHAT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$9.67
Piyasa Değeri
$768M
P/E (TTM)
-3.5
EPS (TTM)
$-3.03
Gelir (TTM)
$175M
Temettü Verimi
—
ROE
52.4%
D/E Borç/Özsermaye
-0.5
52 Haftlık Aralık
$8 – $18
PHAT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$175M
2022-12-31
→
2025-12-31
Hisse Başına Kâr
$-3.03
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
$-167M
2019-12-31
→
2025-12-31
Marjlar
-126.4%
2023-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
PHAT
Akran Ortalaması
P/E (TTM)
-3.5
11.7
P/S (TTM) (F/S (TTM))
4.4
5.4
P/B (F/D)
-1.8
3.7
EV / EBITDA
-5.3
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-4.6
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
PHAT
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
87.1%
83.9%
Operating Margin (Faaliyet Kâr Marjı)
-91.4%
—
Net Profit Margin (Net Kâr Marjı)
-126.4%
-45.6%
ROA
-69.4%
-25.4%
ROE
52.4%
-27.1%
ROIC
69.8%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
PHAT
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
-0.5
—
Current Ratio (Cari Oran)
1.7
4.6
Quick Ratio (Cari Oran)
1.6
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
PHAT
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
216.9%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
PHAT
Akran Ortalaması
PHAT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
17 analist
- Güçlü Al 6 35,3%
- Al 9 52,9%
- Tut 2 11,8%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
10 analist · 2026-08-18
Medyan
$21.50
← Tüm hedeflerin altında
$9.67
Düşük
$13.00
Yüksek
$29.00
Medyan hedef
$21.50
+122,3%
Ortalama hedef
$21.50
+122,3%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.02%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.21 | $-0.26 | 0.05% |
| 31 Mart 2026 | $-0.37 | $-0.33 | -0.04% |
| 31 Aralık 2025 | $-0.29 | $-0.39 | 0.10% |
| 30 Eylül 2025 | $-0.41 | $-0.56 | 0.15% |
| 30 Haziran 2025 | $-1.05 | $-1.06 | 0.01% |
| 31 Mart 2025 | $-1.31 | $-1.17 | -0.14% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| SGP | — | — | — | — | 50.0% | — |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | — |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 18
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $175M | $55M | $682.0K | $0 | |
| Cost of Revenue | $23M | $8M | $167.0K | $0 | |
| Gross Profit | $153M | $47M | $515.0K | $0 | |
| R&D Expense | $33M | $34M | $50M | $71M | |
| SG&A Expense | $280M | $291M | $118M | $101M | |
| Operating Expenses | $312M | $325M | $168M | $172M | |
| Operating Income | $-160M | $-277M | $-167M | $-172M | |
| Interest Expense | · | · | $42M | $27M | |
| Interest Income | $7M | $15M | $8M | $2M | |
| Other Non-op | $-190.0K | $-8.0K | $-188.0K | $-110.0K | |
| Pretax Income | $-221M | $-334M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-221M | $-334M | $-202M | $-198M | |
| EPS (Basic) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| EPS (Diluted) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| Shares (Basic) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| Shares (Diluted) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| EBITDA | $-159M | $-277M | $-167M | $-172M |
Bilanço 24
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $130M | $297M | $381M | $155M | |
| Receivables | $78M | $39M | $2M | $0 | |
| Inventory | $6M | $3M | $1M | $0 | |
| Prepaid Expense | $15M | $21M | $13M | $5M | |
| Current Assets | $229M | $360M | $397M | $161M | |
| PP&E (Net) | $1M | $1M | $2M | $1M | |
| PP&E (Gross) | $5M | $4M | $4M | $3M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | |
| Other Non-current Assets | $3M | $2M | $2M | $299.0K | |
| Total Assets | $259M | $378M | $414M | $165M | |
| Accounts Payable | $5M | $11M | $13M | $10M | |
| Accrued Liabilities | $90M | $53M | $17M | $15M | |
| Current Liabilities | $132M | $86M | $39M | $26M | |
| Capital Leases | $2M | · | $462.0K | $1M | |
| Other Non-current Liabilities | $4M | $12M | $10M | $8M | |
| Total Liabilities | $697M | $632M | $487M | $240M | |
| Long-term Debt | $209M | $201M | $138M | $95M | |
| Total Debt | $209M | $201M | $138M | $95M | |
| Common Stock | $6.0K | $6.0K | $5.0K | $3.0K | |
| Retained Earnings | $-1.48B | $-1.26B | $-929M | $-727M | |
| Treasury Stock | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-438M | $-254M | $-73M | $-75M | |
| Liabilities + Equity | $259M | $378M | $414M | $165M | |
| Shares Outstanding | 71,419,025 | 68,518,238 | 57,970,044 | 41,468,871 |
Nakit Akışı 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $633.0K | $795.0K | $575.0K | $620.0K | |
| Stock-based Comp | $29M | $24M | $45M | $24M | |
| Other Non-cash | $25M | $43M | $18M | $26M | |
| Operating Cash Flow | $-167M | $-267M | $-138M | $-147M | |
| CapEx | $229.0K | $135.0K | $2M | $1M | |
| Investing Cash Flow | $-229.0K | $-135.0K | $-2M | $-1M | |
| Debt Issued | $0 | $59M | $39M | $0 | |
| Net Debt Issued | $0 | $59M | $39M | · | |
| Stock Issued | · | · | $14M | · | |
| Financing Cash Flow | $-288.0K | $183M | $368M | $120M | |
| Net Change in Cash | $-167M | $-84M | $228M | $-28M | |
| Free Cash Flow | $-167M | $-267M | $-139M | $-148M |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 87.1% | 85.6% | 75.5% | · | |
| Operating Margin | -91.4% | -502.2% | -24532.5% | · | |
| Net Margin | -126.4% | -605.1% | -29558.9% | · | |
| Pretax Margin | -126.4% | · | · | · | |
| EBITDA Margin | -91.0% | -500.8% | -24448.2% | · | |
| ROA | -69.4% | -84.4% | -69.7% | -111.6% | |
| ROE | 52.4% | 151.7% | 445.4% | 390.6% | |
| ROIC | 69.8% | · | · | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.7 | 4.2 | 10.2 | 6.1 | |
| Quick Ratio | 1.6 | 3.9 | 9.9 | 5.9 | |
| Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| LT Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| Interest Coverage | · | · | -4.0 | -6.3 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.1 | 0.0 | · | |
| Inventory Turnover | 5.2 | 3.6 | 0.3 | · | |
| Receivables Turnover | 3.0 | 2.7 | 0.8 | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 216.9% | 8001.5% | · | · |
Değerleme (TTM) 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $175M | $55M | $682.0K | $0 | |
| Net Income TTM | $-221M | $-334M | $-202M | $-198M | |
| Market Cap | $1.18B | $471M | $529M | $465M | |
| Enterprise Value | $1.26B | $375M | $286M | $405M | |
| P/E | -5.5 | -1.5 | -2.3 | -2.2 | |
| P/S | 6.8 | 8.5 | 776.1 | · | |
| P/B | -2.7 | -1.9 | -7.3 | -6.2 | |
| P / Cash Flow | -7.1 | -1.8 | -3.8 | -3.2 | |
| P / FCF | -7.1 | -1.8 | -3.8 | -3.2 | |
| EV / EBITDA | -7.9 | -1.4 | -1.7 | -2.4 | |
| EV / FCF | -7.6 | -1.4 | -2.1 | -2.7 | |
| EV / Revenue | 7.2 | 6.8 | 418.9 | · | |
| Earnings Yield | -18.3% | -65.1% | -43.0% | -45.0% |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $74M | $58M | $58M | $50M | $40M | $29M | $30M | $16M | $7M | $2M | $682.0K | $0 | $0 | $0 | |
| Cost of Revenue | $15M | $12M | $8M | $6M | $5M | $4M | $4M | $2M | $1M | $426.0K | $167.0K | $0 | $0 | $0 | |
| Gross Profit | $59M | $46M | $50M | $43M | $34M | $25M | $26M | $14M | $6M | $1M | $515.0K | $0 | $0 | $0 | |
| R&D Expense | $8M | $8M | $7M | $7M | $9M | $9M | $9M | $9M | $7M | $9M | $13M | $12M | $13M | $11M | |
| SG&A Expense | $55M | $54M | $48M | $52M | $85M | $94M | $77M | $76M | $76M | $62M | $57M | $23M | $19M | $19M | |
| Operating Expenses | $63M | $62M | $56M | $59M | $94M | $104M | $85M | $85M | $83M | $71M | $70M | $36M | $32M | $30M | |
| Operating Income | $-4M | $-15M | $-6M | $-15M | $-60M | $-79M | $-59M | $-71M | $-77M | $-70M | $-70M | $-36M | $-32M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | $18M | $17M | · | $10M | $10M | $9M | |
| Interest Income | $2M | $2M | $1M | $1M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $348.0K | $1M | |
| Other Non-op | $-24.0K | $-831.0K | $-6.0K | $-7.0K | $-155.0K | $-22.0K | $49.0K | $-8.0K | $-6.0K | $-43.0K | $-14.0K | $-197.0K | $3.0K | $20.0K | |
| Net Income | $-18M | $-30M | $-21M | $-30M | $-76M | $-94M | $-74M | $-86M | $-91M | $-83M | $-80M | $-43M | $-41M | $-38M | |
| EPS (Basic) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| EPS (Diluted) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| Shares (Basic) | 83,747,104 | 82,050,618 | -144,913,285 | 73,396,435 | 72,466,203 | 71,969,411 | -118,381,262 | 64,627,847 | 58,558,145 | 58,371,480 | -96,348,323 | 56,782,379 | 48,500,516 | 42,354,520 | |
| Shares (Diluted) | 83,747,104 | 82,050,618 | -144,913,285 | 73,396,435 | 72,466,203 | 71,969,411 | -118,381,262 | 64,627,847 | 58,558,145 | 58,371,480 | -96,348,323 | 56,782,379 | 48,500,516 | 42,354,520 | |
| EBITDA | $-4M | $-15M | · | $-15M | $-60M | $-79M | · | $-71M | $-77M | $-70M | · | $-36M | $-32M | $-30M |
Bilanço 24
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $182M | $181M | $130M | $135M | $150M | $212M | $297M | $335M | $276M | $322M | $381M | $214M | $249M | $130M | |
| Receivables | $97M | $81M | $78M | $56M | $51M | $36M | $39M | $21M | $11M | $4M | $2M | · | · | · | |
| Inventory | $8M | $7M | $6M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $1M | $111.0K | $111.0K | · | |
| Prepaid Expense | $8M | $8M | $15M | $13M | $15M | $13M | $21M | $15M | $15M | $13M | $13M | $13M | $9M | $10M | |
| Current Assets | $296M | $277M | $229M | $208M | $219M | $265M | $360M | $374M | $305M | $340M | $397M | $227M | $258M | $140M | |
| PP&E (Net) | $971.0K | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | $5M | · | · | · | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $299.0K | |
| Total Assets | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Accounts Payable | $5M | $6M | $5M | $1M | $4M | $12M | $11M | $7M | $8M | $8M | $13M | $6M | $4M | $5M | |
| Accrued Liabilities | $109M | $83M | $90M | $65M | $64M | $43M | $53M | $36M | $27M | $17M | $17M | $13M | $15M | $8M | |
| Current Liabilities | $154M | $125M | $132M | $93M | $92M | $74M | $86M | $65M | $47M | $43M | $39M | $24M | $22M | $14M | |
| Capital Leases | $2M | $2M | $2M | $2M | $589.0K | $0 | · | $0 | $133.0K | $292.0K | $462.0K | $628.0K | $789.0K | $945.0K | |
| Other Non-current Liabilities | $4M | $4M | $4M | $12M | $12M | $12M | $12M | $11M | $10M | $10M | $10M | $8M | $8M | $8M | |
| Total Liabilities | $671M | $642M | $697M | $663M | $656M | $633M | $632M | $574M | $553M | $505M | $487M | $255M | $247M | $234M | |
| Long-term Debt | $165M | $164M | $209M | $207M | $205M | $203M | $201M | $176M | $174M | $149M | $138M | $99M | $98M | $97M | |
| Total Debt | $165M | $164M | · | $207M | $205M | $203M | · | $176M | $174M | $149M | · | $99M | $98M | $97M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | |
| Retained Earnings | $-1.53B | $-1.51B | $-1.48B | $-1.46B | $-1.43B | $-1.36B | $-1.26B | $-1.19B | $-1.10B | $-1.01B | $-929M | $-849M | $-806M | $-765M | |
| Treasury Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-344M | $-337M | $-438M | $-423M | $-406M | $-338M | $-254M | $-187M | $-234M | $-149M | $-73M | $-18M | $18M | $-90M | |
| Liabilities + Equity | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Shares Outstanding | 80,070,048 | 79,442,367 | 71,419,025 | 71,043,149 | 70,104,419 | 69,638,070 | 68,518,238 | 68,323,938 | 58,601,025 | 58,524,101 | 57,970,044 | 56,809,085 | 56,639,085 | 43,571,140 |
Nakit Akışı 12
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $114.0K | $110.0K | $128.0K | $156.0K | $172.0K | $177.0K | $193.0K | $191.0K | $197.0K | $214.0K | $185.0K | $121.0K | $123.0K | $146.0K | |
| Stock-based Comp | $7M | $6M | $6M | $9M | $8M | $6M | $7M | $6M | $6M | $6M | $25M | $6M | $7M | $7M | |
| Other Non-cash | · | $9M | · | · | · | $4M | · | · | · | $8M | · | · | · | $-9M | |
| Operating Cash Flow | $-2M | $-16M | $-5M | $-14M | $-63M | $-85M | $-63M | $-64M | $-71M | $-69M | $-44M | $-32M | $-22M | $-40M | |
| CapEx | $44.0K | $61.0K | $87.0K | $27.0K | $97.0K | $18.0K | $5.0K | $44.0K | $46.0K | $40.0K | $475.0K | $939.0K | $6.0K | $214.0K | |
| Investing Cash Flow | $-44.0K | $-61.0K | $-87.0K | $-27.0K | $-97.0K | $-18.0K | $-5.0K | $-44.0K | $-46.0K | $-40.0K | $-475.0K | $-939.0K | $-6.0K | $-214.0K | |
| Debt Issued | $0 | $173M | $0 | $0 | $0 | $0 | $25M | $0 | $25M | $10M | $39M | $0 | $0 | $0 | |
| Net Debt Issued | · | $-56M | · | · | · | $0 | · | · | · | $10M | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $4M | $67M | $-97.0K | $-271.0K | $80.0K | $0 | $26M | $122M | $25M | $10M | $212M | $13.0K | $142M | $14M | |
| Net Change in Cash | $2M | $51M | $-5M | $-14M | $-63M | $-85M | $-37M | $58M | $-46M | $-59M | $168M | $-33M | $119M | $-26M | |
| Free Cash Flow | · | $-16M | · | · | · | $-85M | · | · | · | $-69M | · | · | · | $-40M |
Kârlılık 6
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 79.7% | 79.4% | · | 87.5% | 87.2% | 86.9% | · | 85.6% | 81.2% | 77.7% | · | · | · | · | |
| Operating Margin | -5.3% | -26.6% | · | -30.9% | -151.7% | -276.5% | · | -433.0% | -1055.4% | -3658.7% | · | · | · | · | |
| Net Margin | -23.7% | -52.1% | · | -60.6% | -191.9% | -330.7% | · | -523.3% | -1248.6% | -4333.3% | · | · | · | · | |
| EBITDA Margin | -5.3% | -26.4% | · | -30.9% | -151.7% | -275.9% | · | -433.0% | -1055.4% | -3647.5% | · | · | · | · | |
| ROA | -6.1% | -10.1% | · | -9.6% | -26.6% | -29.0% | · | -27.4% | -31.3% | -33.1% | · | -19.7% | -17.1% | -25.8% | |
| ROE | 4.7% | 9.0% | · | 9.8% | 23.7% | 38.7% | · | 83.5% | 84.6% | 69.4% | · | 195.7% | -772.9% | 145.0% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.2 | · | 2.2 | 2.4 | 3.6 | · | 5.7 | 6.5 | 7.8 | · | 9.5 | 12.0 | 9.7 | |
| Quick Ratio | 1.8 | 2.1 | · | 2.1 | 2.2 | 3.4 | · | 5.4 | 6.1 | 7.5 | · | 8.9 | 11.6 | 9.0 | |
| Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| LT Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -4.4 | -4.1 | · | -3.5 | -3.3 | -3.3 |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | 2.7 | 2.5 | · | 1.8 | 1.8 | 1.6 | · | 1.5 | 1.2 | 0.6 | · | · | · | · | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.3 | 1.3 | 1.4 | · | 1.6 | 1.3 | 1.0 | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $222M | $176M | · | $134M | $92M | $54M | · | $26M | $9M | $2M | · | · | · | · | |
| Net Income TTM | $-154M | $-230M | · | $-286M | $-347M | $-354M | · | $-303M | $-259M | $-205M | · | $-173M | $-181M | $-180M | |
| Market Cap | $869M | $883M | · | $836M | $672M | $437M | · | $1.24B | $604M | $622M | · | $589M | $811M | $311M | |
| Enterprise Value | $851M | $865M | · | $908M | $728M | $428M | · | $1.08B | $502M | $448M | · | $475M | $660M | $278M | |
| P/E | -5.3 | -3.5 | · | -2.9 | -1.8 | -1.1 | · | -3.6 | -2.2 | -2.7 | · | -2.7 | -3.3 | -1.5 | |
| P/S | 3.9 | 5.0 | · | 6.2 | 7.3 | 8.1 | · | 48.3 | 65.4 | 325.1 | · | · | · | · | |
| P/B | -2.5 | -2.6 | · | -2.0 | -1.7 | -1.3 | · | -6.6 | -2.6 | -4.2 | · | -33.1 | 46.1 | -3.4 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 46.1 | · | |
| P / Cash Flow | · | -56.4 | · | · | · | -5.1 | · | · | · | -9.0 | · | · | · | -7.8 | |
| P / FCF | · | -56.2 | · | · | · | -5.1 | · | · | · | -9.0 | · | · | · | -7.8 | |
| EV / EBITDA | -214.6 | -56.3 | · | -59.5 | -12.1 | -5.4 | · | -15.2 | -6.5 | -6.4 | · | -13.3 | -20.8 | -9.3 | |
| EV / FCF | · | -55.1 | · | · | · | -5.0 | · | · | · | -6.5 | · | · | · | -7.0 | |
| EV / Revenue | 3.8 | 4.9 | · | 6.8 | 7.9 | 7.9 | · | 42.1 | 54.3 | 234.5 | · | · | · | · | |
| Earnings Yield | -18.8% | -28.3% | · | -34.8% | -54.6% | -89.5% | · | -28.0% | -44.5% | -36.8% | · | -36.7% | -30.6% | -64.6% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $175M | $55M | $682.0K | $0 | — |
| Brüt Kâr Marjı % | 87.1% | 85.6% | 75.5% | — | — |
| Faaliyet Kâr Marjı % | -91.4% | -502.2% | -24532.5% | — | — |
| Net Gelir | $-221M | $-334M | $-202M | $-198M | $-144M |
| Seyreltilmiş Hisse Başı Kâr | $-3.03 | $-5.29 | $-3.93 | $-5.05 | $-3.89 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | -0.5 | -0.8 | -1.9 | -1.3 | 1.2 |
| Cari Oran | 1.7 | 4.2 | 10.2 | 6.1 | 9.9 |
| Cari Oran | 1.6 | 3.9 | 9.9 | 5.9 | 9.7 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-167M | $-267M | $-139M | $-148M | $-149M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 179 dosya · $617.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 34 (-4 önceki Ç'ye göre) | 31 (-4 önceki Ç'ye göre) | 51 (-22 önceki Ç'ye göre) | 50 (+12 önceki Ç'ye göre) | -470K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $135.261.406 | 12.466.489 | 21,91% | Hisse senetleri |
| Medicxi Ventures Management (Jersey) Ltd | $80.990.606 | 7.464.572 | 13,12% | Hisse senetleri |
| Carlyle Group Inc. | $37.940.367 | 3.496.808 | 6,15% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $36.627.799 | 3.375.834 | 5,93% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $28.827.842 | 2.656.944 | 4,67% | Hisse senetleri |
| NEA Management Company, LLC | $21.267.834 | 1.960.169 | 3,44% | Hisse senetleri |
| 683 Capital Management, LLC | $20.072.501 | 1.850.000 | 3,25% | Hisse senetleri |
| STATE STREET CORP | $17.211.605 | 1.586.323 | 2,79% | Hisse senetleri |
| Catalys Pacific, LLC | $16.208.316 | 1.493.854 | 2,63% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $15.871.000 | 1.462.738 | 2,57% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $15.552.303 | 1.433.392 | 2,52% | Hisse senetleri |
| WASATCH ADVISORS LP | $14.897.577 | 1.340.916 | 2,41% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $12.271.034 | 1.130.751 | 1,99% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $11.413.256 | 1.051.913 | 1,85% | Hisse senetleri |
| Propel Bio Management, LLC | $11.396.384 | 1.050.358 | 1,85% | Hisse senetleri |
| Point72 Asset Management, L.P. | $11.090.794 | 1.022.193 | 1,80% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8.643.446 | 796.631 | 1,40% | Hisse senetleri |
| SummitTX Capital, L.P. | $8.566.618 | 789.550 | 1,39% | Hisse senetleri |
| EcoR1 Capital, LLC | $6.781.250 | 625.000 | 1,10% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $5.772.200 | 532.000 | 0,93% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $5.631.975 | 519.076 | 0,91% | Hisse senetleri |
| CITADEL ADVISORS LLC | $5.216.680 | 480.800 | 0,84% | Alım opsiyonu |
| VANGUARD GROUP INC | $4.969.501 | 299.548 | 0,80% | Hisse senetleri |
| StepStone Group LP | $4.689.364 | 422.085 | 0,76% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.547.170 | 419.094 | 0,74% | Hisse senetleri |
| Woodline Partners LP | $4.004.214 | 369.052 | 0,65% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $3.847.117 | 354.573 | 0,62% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $3.189.358 | 293.950 | 0,52% | Hisse senetleri |
| Simplify Asset Management Inc. | $2.704.547 | 249.267 | 0,44% | Hisse senetleri |
| JPMORGAN CHASE & CO | $2.616.050 | 240.667 | 0,42% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $2.456.440 | 226.400 | 0,40% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.281.755 | 210.300 | 0,37% | Alım opsiyonu |
| NewEdge Advisors, LLC | $2.212.988 | 203.962 | 0,36% | Hisse senetleri |
| Avidity Partners Management LP | $2.170.000 | 200.000 | 0,35% | Hisse senetleri |
| Jump Financial, LLC | $2.081.746 | 191.866 | 0,34% | Hisse senetleri |
| Opaleye Management Inc. | $2.013.641 | 185.589 | 0,33% | Hisse senetleri |
| CITADEL ADVISORS LLC | $2.006.176 | 184.901 | 0,32% | Hisse senetleri |
| Trexquant Investment LP | $1.886.641 | 173.884 | 0,31% | Hisse senetleri |
| Jones Hill Capital LP | $1.752.123 | 161.486 | 0,28% | Hisse senetleri |
| MARSHALL WACE, LLP | $1.751.191 | 161.400 | 0,28% | Hisse senetleri |
| XTX Topco Ltd | $1.473.777 | 135.832 | 0,24% | Hisse senetleri |
| DIADEMA PARTNERS LP | $1.409.958 | 129.950 | 0,23% | Hisse senetleri |
| SIG BROKERAGE, LP | $1.345.400 | 124.000 | 0,22% | Alım opsiyonu |
| Engineers Gate Manager LP | $1.283.088 | 118.257 | 0,21% | Hisse senetleri |
| Virtus Investment Advisers, LLC | $1.216.708 | 112.139 | 0,20% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $1.178.885 | 108.653 | 0,19% | Hisse senetleri |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1.105.968 | 101.745 | 0,18% | Hisse senetleri |
| JANE STREET GROUP, LLC | $1.096.761 | 101.084 | 0,18% | Hisse senetleri |
| Stratos Wealth Partners, LTD. | $1.085.000 | 100.000 | 0,18% | Hisse senetleri |
| Swiss National Bank | $1.071.980 | 98.800 | 0,17% | Hisse senetleri |
| GILDER GAGNON HOWE & CO LLC | $956.254 | 88.134 | 0,15% | Hisse senetleri |
| Stonepine Capital Management, LLC | $922.358 | 85.010 | 0,15% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $838.879 | 77.316 | 0,14% | Hisse senetleri |
| JANE STREET GROUP, LLC | $837.620 | 77.200 | 0,14% | Alım opsiyonu |
| BlackRock, Inc. | $835.548 | 77.009 | 0,14% | Hisse senetleri |
| Campbell & CO Investment Adviser LLC | $746.035 | 68.759 | 0,12% | Hisse senetleri |
| Penn Mutual Asset Management | $681.402 | 62.802 | 0,11% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $675.771 | 62.283 | 0,11% | Hisse senetleri |
| RHUMBLINE ADVISERS | $654.740 | 60.346 | 0,11% | Hisse senetleri |
| UBS Group AG | $635.105 | 58.535 | 0,10% | Hisse senetleri |
| Birchview Capital, LP | $596.750 | 55.000 | 0,10% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $585.206 | 53.936 | 0,09% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $547.612 | 49.290 | 0,09% | Hisse senetleri |
| CITIGROUP INC | $543.661 | 50.107 | 0,09% | Hisse senetleri |
| Bank of New York Mellon Corp | $540.037 | 49.773 | 0,09% | Hisse senetleri |
| Pale Fire Capital SE | $539.386 | 49.713 | 0,09% | Hisse senetleri |
| NOMURA HOLDINGS INC | $532.735 | 49.100 | 0,09% | Satım opsiyonu |
| Man Group plc | $528.167 | 48.679 | 0,09% | Hisse senetleri |
| AlphaQuest LLC | $468.668 | 28.250 | 0,08% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $465.465 | 42.900 | 0,08% | Hisse senetleri |
| Quantbot Technologies LP | $463.892 | 42.755 | 0,08% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $459.866 | 42.384 | 0,07% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $446.866 | 40.222 | 0,07% | Hisse senetleri |
| BARCLAYS PLC | $435.660 | 40.153 | 0,07% | Hisse senetleri |
| NOMURA HOLDINGS INC | $434.000 | 40.000 | 0,07% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $432.318 | 39.845 | 0,07% | Hisse senetleri |
| Fiduciary Trust Co | $387.681 | 35.731 | 0,06% | Hisse senetleri |
| Nebula Research & Development LLC | $363.816 | 37.937 | 0,06% | Hisse senetleri |
| Persistent Asset Partners Ltd | $359.753 | 33.157 | 0,06% | Hisse senetleri |
| ALLSTATE CORP | $356.694 | 32.875 | 0,06% | Hisse senetleri |
| Squarepoint Ops LLC | $342.806 | 31.595 | 0,06% | Hisse senetleri |
| CITADEL ADVISORS LLC | $337.435 | 31.100 | 0,05% | Satım opsiyonu |
| VANGUARD ASSET MANAGEMENT, Ltd | $309.290 | 28.506 | 0,05% | Hisse senetleri |
| MetLife Investment Management, LLC | $304.961 | 28.107 | 0,05% | Hisse senetleri |
| Kera Capital Partners, Inc. | $291.062 | 26.826 | 0,05% | Hisse senetleri |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $280.342 | 25.838 | 0,05% | Hisse senetleri |
| Caption Management, LLC | $260.400 | 24.000 | 0,04% | Alım opsiyonu |
| Caption Management, LLC | $260.400 | 24.000 | 0,04% | Satım opsiyonu |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $245.720 | 22.647 | 0,04% | Hisse senetleri |
| COMMONWEALTH EQUITY SERVICES, LLC | $244.500 | 22.535 | 0,04% | Hisse senetleri |
| Summit Financial Wealth Advisors, LLC | $240.252 | 22.143 | 0,04% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $239.403 | 21.500 | 0,04% | Hisse senetleri |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $236.198 | 18.731 | 0,04% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $225.344 | 20.769 | 0,04% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $220.255 | 20.300 | 0,04% | Satım opsiyonu |
| Invesco Ltd. | $211.065 | 19.453 | 0,03% | Hisse senetleri |
| INSPIRION WEALTH ADVISORS, LLC | $209.794 | 19.914 | 0,03% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $192.316 | 17.725 | 0,03% | Hisse senetleri |
| State of Wyoming | $191.383 | 17.639 | 0,03% | Hisse senetleri |
| PROFUND ADVISORS LLC | $187.455 | 17.277 | 0,03% | Hisse senetleri |
Şirket yöneticileri 20 içeriden öğrenenler · 9 yöneticiler · 12 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Steven L Basta | President and CEO | 10 Şubat 2026 F | 373.315 | 0 | 0 | $0 |
| Molly Henderson | CFO and CBO | 07 Nisan 2025 S | 89.868 | 0 | 0 | $0 |
| Todd P. Branning | Chief Financial Officer | 28 Ocak 2021 A | — | 0 | 0 | $0 |
| Terrie Curran | President and Chief Executive | 27 Şubat 2025 A | 360.465 | 0 | 0 | $0 |
| Azmi Nabulsi | Chief Operating Officer | 27 Şubat 2025 A | 312.590 | 0 | 0 | $0 |
| Robert Charles Breedlove | Principal Accounting Officer | 14 Temmuz 2026 F | 59.925 | 0 | 2 | $-12.652 |
| Anne Marie Cook | Chief Legal Off. & Corp. Sec. | 10 Şubat 2026 F | 88.660 | 0 | 0 | $0 |
| Sanjeev Narula | Chief Financial & Bus. Officer | 02 Ocak 2026 A | 226.715 | 0 | 0 | $0 |
| Anthony J. Guzzo | VP, Chief Accounting Officer | 19 Ocak 2022 A | 8.399 | 0 | 0 | $0 |
| Asit Parikh | Yönetim kurulu üyesi | 22 Mayıs 2026 G | 148.500 | 0 | 0 | $0 |
| Mark Stenhouse | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 54.122 | 0 | 0 | $0 |
| Theodore R Schroeder | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 45.122 | 0 | 0 | $0 |
| James N. Topper | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 66.718 | 0 | 0 | $0 |
| Frank Karbe | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 91.622 | 0 | 0 | $0 |
| Michael F Cola | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 63.920 | 0 | 0 | $0 |
| Heidi Kunz | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 54.122 | 0 | 0 | $0 |
| David A Socks | Yönetim kurulu üyesi | 23 Mayıs 2024 A | 19.500 | 0 | 0 | $0 |
| Tadataka Yamada | Yönetim kurulu üyesi | 21 Mayıs 2021 A | — | 0 | 0 | $0 |
| Jonathan S. Edwards | Yönetim kurulu üyesi | 29 Ekim 2019 C | 47.984 | 0 | 0 | $0 |
| Takeda Pharmaceutical Company Limited | — | 24 Ocak 2024 S | 3.755.583 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×3 başvurular | 04 Kasım 2025 | 8,60% | Değişiklik | — | SEC |
| Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes ×8 başvurular | 22 Ağustos 2024 | — | İlk başvuru | Pasif yatırım | SEC |
| Takeda Pharmaceutical Company Limited ×3 başvurular | 10 Nisan 2024 | — | İlk başvuru | — | SEC |
| Frazier Life Sciences IX, L.P ., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes | 26 Mayıs 2023 | — | İlk başvuru | Pasif yatırım | SEC |
| S.S. OR ×5 başvurular | 12 Kasım 2021 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 34 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,23% | 64.997 NS | 30 Nisan 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,01% | 11.659 NS | 30 Nisan 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,05% | 49.552 NS | 31 Mayıs 2026 | N-PORT |
| BIB · ProShares Trust | 0,04% | 2.912 NS | 31 Mayıs 2026 | N-PORT |
| RSSL · Global X Funds | 0,02% | 20.112 NS | 30 Nisan 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2.182 NS | 31 Mayıs 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 236.650 NS | 31 Mayıs 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 21.971 NS | 30 Nisan 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 1.707 NS | 31 Mayıs 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1.727 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 43 NS | 31 Mayıs 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.333 NS | 31 Mayıs 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 205 NS | 31 Mayıs 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 33.490 NS | 31 Mayıs 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 Temmuz 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| ITOT · iShares Trust | — | — | 05 Ağustos 2026 | Günlük |
| IWV · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IWN · iShares Trust | — | — | 17 Ağustos 2026 | Günlük |
| IWO · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IWM · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IBB · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IWC · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IHE · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | — | — | 20 Temmuz 2026 | Günlük |
| ISCB · iShares Trust | — | — | 05 Ağustos 2026 | Günlük |
| ISCG · iShares Trust | — | — | 05 Ağustos 2026 | Günlük |
| WSML · iShares Trust | — | — | 05 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 Temmuz 2026 | Günlük |